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A report on the third biennial Cold Spring Harbor
Laboratory meeting on Germ Cells, Cold Spring Harbor,
USA, 9-13 October 2002.
Primordial germ cells (PGCs) are the embryonic precursors
of the gametes. In most species, PGCs spend much of early
development as nomadic residents within other developing
tissues. Despite the changing terrain of the embryo, PGCs
are able to remain pluripotent, with the potential to develop
into many types of specialized cells, and they eventually
home in on the position of the developing gonad. Once they
reach the gonad, germ cells undergo a sexually dimorphic
process of differentiation that eventually (after days, weeks
or years, depending on the organism) culminates in reduc-
tive divisions (meiosis) giving rise to the haploid sperm or
egg. The accuracy and efficiency of this process has profound
effects on the health and fitness of future generations, so
germ cells are of interest to the medical community. 
Historically, most advances in germ cell biology have come
from genetically tractable organisms such as Drosophila and
Caenorhabditis elegans where ‘forward’, or traditional,
genetic strategies were used to identify genes required at
various stages of PGC development. Spontaneous or targeted
mutations - ‘reverse genetics’ - in less genetically tractable
organisms have also contributed to our understanding of how
PGCs function in mammalian systems. To expand these
strategies, John Schimenti (The Jackson Laboratory, Bar
Harbor, USA) has recently spearheaded a move to apply
forward genetics  to studies of PGCs in the mouse. In his talk,
Schimenti described mutagenesis strategies for generating
animals with fertility defects. Chemical mutagenesis, either in
males or embryonic stem cells, followed by the generation of
chimeric mice can result in dominant or recessive mutations
affecting fertility. Schimenti described two sets of mutants
recovered from these screens, the spermatogonial depletion
(sgdp) mutants that exhibit fewer or no germ cells in the
testis, and the meiosis (mei) mutants that are defective in
meiosis. Currently, few of these mutations have been
mapped to specific genes, but Schimenti was able to
describe the mei1 mutation in detail. In mei1 mutants, PGCs
arrest during the prophase of meiosis I and have defects in
chromosomal synapsis. The DNA-repair protein Rad51 is
not recruited to meiotic chromosomes in these animals,
indicating that single-strand breaks do not occur or that
Rad51 binding is blocked in this strain. The mutation was
mapped near the gene for disrupted meiotic cDNA 1 (Dmc1)
on chromosome 15 and identified fortuitously when an
expressed sequence tag (EST) was mapped to this region.
The  Mei1 gene is a novel gene with no known functional
domains; it has homologs in humans, chickens and
zebrafish, however, indicating that it may have a conserved
function in vertebrate meiosis.
In all systems, from flies to humans, genomic and bioinfor-
matic approaches (including microarrays, differential display
and whole-genome sequencing) were prominent, and this
article highlights the most exciting discoveries stemming from
these techniques. In the field of germ cell origins, Yasuhisa
Matsui (Osaka Medical Center for Maternal and Child Health,
Japan) and Azim Surani (Wellcome/CRC Institute, Cam-
bridge, UK) gave back-to-back talks about how the PGC
lineage is established in mammals. In the mouse, PGCs are
induced to form during the first third of gestation at the junc-
tion between the embryo (epiblast) and the extraembryonic
tissue. The process occurs in two steps: firstly, at embryonic
day 6.5 (E6.5), bone morphogenic proteins (BMP4 and
BMP8) induce the proximal epiblast cells to become compe-
tent to develop into PGCs; and secondly, competent cells
become committed to the PGC lineage by E7.25, but this
commitment process is poorly understood. By culturing iso-
lated epiblasts, Matsui was able to determine the time at
which epiblast cells become responsive to BMP4 and BMP8.
He also found that the response of these cells correlates withexpression of Smad5, a known mediator of BMP signals. To
identify new factors involved in restricting cells to the PGC
lineage, Matsui and coworkers performed differential display
analysis. They compared mRNAs from individual PGCs iso-
lated from E8.5 embryos to those from individual blastocyst
cells, which are obtained prior to gastrulation at E4-5. They
identified 11 candidate genes that were enriched in PGCs,
including two known interferon-inducible transcripts (Mil-
1/Fragilis and Mil-2). On the basis of this observation, their
current hypothesis is that an interferon-like signal may coop-
erate with BMP4 and BMP8 to specify PGC fate. Surani and
colleagues took a similar approach to identify novel genes ele-
vated in nascent PGCs. They used differential display and
single-cell microarray analysis to compare the expression of
genes in individual E8.5 PGCs with individual neighboring
somatic cells. They also identified Fragilis and another gene,
Stella, as interesting candidates. Fragilis encodes a trans-
membrane protein that has been shown to mediate adhesion
between cells of the same type. The function of the Stella gene
product is uncertain but it has domains characteristic of pro-
teins involved in splicing. Additionally, from their differential
screen, Surani and colleagues found that expression of the
homeobox transcription factor gene Hoxb1 is excluded from
PGCs. They propose a model whereby the BMP4 and BMP8
signal leads to expression of Fragilis. As a result of differen-
tial adhesion, the highest expressers become segregated and
begin to express markers such as Stella, indicating commit-
ment to the PGC fate. Lower levels of Fragilis may correlate
with Hoxb1 expression, which Surani and colleagues propose
blocks PGC fate and causes the cells to develop along a
somatic path.
In discussing the embryonic germline, Erez Raz (Max Planck
Institute for Biophysical Chemistry, Göttingen, Germany)
described a new signaling pathway that guides migrating
PGCs in zebrafish embryos. In this system, PGCs form as a
result of the inheritance of maternal determinants. The
maternally provided mRNA and proteins become parti-
tioned into the zebrafish PGCs during the early cleavage
stages of development of the zygote, resulting in the forma-
tion of four clusters of PGCs within the blastocyst-stage
embryo. These widely separated clusters realign during gas-
trulation, and the PGCs accumulate at the junction between
the head the trunk. The resulting line of PGCs then separates
into two as the cells move to the left or right forming clusters
at the sides of the embryo. Then, the two lateral groups of
PGCs move posterially as the PGCs migrate to the develop-
ing gonads (marked by expression of the zebrafish homolog
of the Wilm’s Tumor gene). In order to identify genes that
are involved in orchestrating this elaborate pattern of move-
ments, Raz and colleagues, together with Mermaid Pharma-
ceuticals (Hamburg, Germany), conducted a screen based on
morpholino-modified antisense oligonucleotides to target
around 10,000 zebrafish cDNAs. Depletion of one gene,
encoding the chemokine receptor CXCR4, caused PGCs to
stray into inappropriate locations. In mammals, CXCR4 is
the receptor for stromal-derived factor (SDF), a chemokine
involved in many migratory processes including growth-
cone guidance, leukocyte trafficking and tumor metastasis.
Based on in situ hybridization analysis, Raz and coworkers
found that zebrafish SDF was expressed at all sites in the
embryo where PGCs normally accumulate, and that changes
in its expression perfectly match the times at which PGCs
realign. They then used morpholino oligonucleotides to
deplete SDF and found that PGCs scatter, instead of accu-
mulating within the gonads. They were also able to ectopi-
cally express SDF (together with a green fluorescent protein
marker) in zebrafish embryos and found that PGCs would
accumulate in these ectopic locations.
Steve Rozen (Whitehead Institute, Cambridge, USA)
described some of the unusual properties of the human Y
chromosome in his talk. Regions of the Y chromosome that
lack a meiotic pairing partner are believed to be undergoing
degradation on an evolutionary time scale. This ‘Rotting Y’
hypothesis is challenged by the finding that these non-
pairing regions contain many genes necessary for male fer-
tility and hence should be selected for evolutionarily. From
the sequence of the human genome, Rozen and coworkers
have identified unusual structural elements in the non-
pairing arm of the Y chromosome, namely long palindromes
with highly conserved arms. Six of these palindromes can be
found on the Y chromosomes of chimpanzee and bonobo,
suggesting that these structures predate the divergence of
humans and chimps. The fact that the palindrome arms are
so highly conserved within species indicates that there may
be gene conversion events and selective pressure to maintain
these structures. Additionally, Rozen and colleagues exam-
ined the distribution of eight Y-linked gene families that are
expressed in the testis and found that all genes were present
within the palindromes, whereas pseudogenes were more
randomly distributed. Rozen suggests several mechanisms
whereby these structures might become fixed during evolu-
tion. One possibility is that duplication of testis-specific
genes within palindromes may confer a breeding advantage
on males. Alternatively or in addition, palindromes could
provide shelter from deleterious mutations that would other-
wise be unmasked in an unpaired chromosome. Finally,
intrachromosomal crossover events (gene conversions)
could stabilize these regions during meiosis and effectively
combat the rotting Y phenomenon.
In summary, the talks discussed here are examples of what
can be done with microarray, differential display and
sequence-based approaches. Novel genes have been identi-
fied that are involved in PGC development, functional screens
have been devised using the massive amounts of new
sequence information, and the completed human genome has
been mined to glean novel insights into human evolution.
There were many other talks and posters utilizing similar
approaches, indicating that the advent of this new technology
has had a clear impact on the field of germ cell biology.
303.2 Genome Biology 2002, Volume 4, Issue 1, Article 303 Molyneaux and Wylie  http://genomebiology.com/2002/4/1/303
Genome Biology 2002, 4:303